At Neko Health we always aim to push the limits of technology and science, to create the best possible product and service for our members to stay ahead of their health.
Research is in our DNA, and many data points that we collect during the visit are used in clinical trials to challenge current hypotheses and foster innovation. The trials we create are funded by us and conducted by our in-house doctors in collaboration with other world-renowned clinicians and institutions.
All the trials we conduct have been reviewed by The Swedish Medical Products Agency (Läkemedelsverket) and the Swedish Ethical Review Authority (Etikprövningsmyndigheten).
It is always voluntary to participate in our studies, but a requirement if you want to get the full Neko Body Scan experience.
Today, we have 5 in-house clinical trials. We call them SCAPIS 2, MIND, Cardio Alpha, DermaFlow Alpha, and Spectrum 1.
Arterial stiffness is a sign of ageing of the cardiovascular system, and it is strongly associated with hypertension and an increased risk of cardiovascular disease.
This clinical trial is about evaluating the suitability of a novel technique, using a combination of a weak laser light and radar (laser-radar). Through studying various correlations and sensitivity for detection of cardiovascular risk, we would like to assess the technique’s potential for use at an early and preventative stage of disease.
The examinationstakes place in connection to the SCAPIS 2 study, at a visit to the cardiovascular laboratory (KFC) at Danderyd’sHospital.
The examinations take about 10 minutes in total.
Diabetes is a life-long disease that can cause damage to the small vessels in the body, the so-called microcirculation. Diabetes microangiopathy is common and may eventually lead to organ dysfunction. Today, we lack proper tools to detect microvascular complications on an early stage, and to prevent further damage to the vessel function before symptoms start to develop.
In this study we wish to investigate skin microvascular function in patients with type 1 diabetes with and without established microvascular complications and healthy subjects, in order to see if we can develop new diagnostic tools to detect diabetes microangiopathy at an early stage.
The examinations will take place on a single visit at the Clinical Research Centerlaboratoryat Danderyd’s Hospital.
The measurements take about 60 minutes in total.
The skin is our biggest organ that changes all the time and varies a lot from person to person. The skin often gives us clues about what is happening in other parts of the body.
This clinical trial is about evaluating the suitability of multi-modal imaging technology that virtually covers the entire body, to assess the potential of screening and early detection of disease.
The multi-modal technology is based on camera systems, which can capture high-resolution color images (visible spectrum), 3D, and thermal images (infrared spectrum).
By studying the correlation and sensitivity between disease states, gradients, and asymmetries in collected image data, the potential can be evaluated.
The examination takes no more than 5 minutes.
Arterial stiffness is a sign of aging of the cardiovascular system, and it is strongly associated with hypertension and increased risk for cardiovascular disease.
This clinical trial is about evaluating the suitability of a novel Laser-Radar-based technology, to assess arterial stiffness and its correlation to cardiovascular risk and diseases.
Some of the data points we collect in this trial:
Heart sounds
Pulse wave analysis
Pulse wave velocity
Blood pressure
ECG
Heart Ultrasound Images
The basic examination takes about 10 minutes, and the extended one 30-40 minutes.
Most skin conditions affect and/or are caused by the skin's microcirculation (blood flow in the smallest vessels). Microcirculation in the skin is also affected by many systemic diseases, such as for example, diabetes and autoimmune diseases.
The disease of large vessels (macro-circulation) can also be caused by basic problems with microcirculation.
Today, there is little opportunity to detect microcirculatory problems early, and it is often discovered when the course of the systemic disease has gone quite far.
This clinical trial will evaluate a trial device that uses a projector to depict patterns on the skin, which the skin absorbs, reflects, and spreads depending on skin composition and structure.
Some of the data points collected in this trial:
The concentration of Oxy-haemoglobin (oxidized haemoglobin)
Deoxy-haemoglobin (non-oxidized haemoglobin)
Total haemoglobin
Oxygenation within the measured skin area
Water concentration within the measured skin area
Melanin concentration
The basic examination takes about 1 minute, and the extended one about 30 minutes. You will also be asked to provide demographic data about yourself and leave a blood test that will be used in the evaluation of this trial device.
Neko Health invests in research and supports clinical studies. For more information and collaboration inquiries, please contact us.